Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:43.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:01:15.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a generic error page. This renders the trial information inaccessible on this URL.
    Difference
    21%
    Check dated 2026-09-20T20:43:49.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new line noting NIH funding (2018 ( U.S. NIH Grant/Contract )) was added to the study's identifiers, and the page footer revision updated to v3.6.6 from v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T17:25:44.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to v3.6.5, replacing the previous revision v3.6.4.
    Difference
    0.0%
    Check dated 2026-08-09T08:54:07.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.4 replacing v3.6.3, indicating a updated build of the page. This reflects a backend/frontend update to the page without altering the displayed study content.
    Difference
    0.0%
    Check dated 2026-07-25T17:46:00.000Z thumbnail image

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.